TLS Beta Pte. Ltd.

10% owner at Intellia Therapeutics, Inc. · on record since May 13, 2016
10% owner at Q32 Bio Inc. · on record since Mar 28, 2018
10% owner at Guardant Health, Inc. · on record since Oct 11, 2018
10% owner at VIRCO MFG CORPORATION · on record since Oct 18, 2019
10% owner at Thimble Point Acquisition Corp. · on record since Dec 9, 2021
10% owner at Social Capital Suvretta Holdings Corp. I · on record since Aug 26, 2022

Insider trading activity of TLS Beta Pte. Ltd.

No transactions on record for TLS Beta Pte. Ltd..

Track record of TLS Beta Pte. Ltd.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of TLS Beta Pte. Ltd.

Co-insiders of TLS Beta Pte. Ltd.

Fullerton Management Pte LtdGuardant Health, Inc. +5
TEMASEK HOLDINGS (PRIVATE) LTDGuardant Health, Inc. +5
Temasek Life Sciences Private LTDGuardant Health, Inc. +5
ORBIMED ADVISORS LLCGuardant Health, Inc. +2
5AM Co-Investors IV, L.P.Q32 Bio Inc. +1
5AM Partners IV, LLCQ32 Bio Inc. +1
5AM Ventures IV, L.P.Q32 Bio Inc. +1
BYBEE CLINTONQ32 Bio Inc. +1
CRANDELL KEITHQ32 Bio Inc. +1
DIEKMAN JOHN DQ32 Bio Inc. +1
NELSEN ROBERTQ32 Bio Inc. +1
Nishar DipchandGuardant Health, Inc. +1
NOVARTIS AGIntellia Therapeutics, Inc. +1
Novartis Institutes for BioMedical Research, Inc.Intellia Therapeutics, Inc. +1
ROCKLAGE SCOTT MQ32 Bio Inc. +1
SB INVESTMENT ADVISERS (UK) LTDGuardant Health, Inc. +1
Schwab Andrew J.Q32 Bio Inc. +1
SOFTBANK VISION FUND (AIV M1) L.P.Guardant Health, Inc. +1
SVF Endurance (Cayman) LtdGuardant Health, Inc. +1
V-Sciences Investments Pte LtdQ32 Bio Inc. +1
5AM Opportunities I (GP), LLCThimble Point Acquisition Corp.
5AM Opportunities I, L.P.Thimble Point Acquisition Corp.
Abu Dhabi Investment AuthorityVIRCO MFG CORPORATION
Alaska Permanent Fund CorpVIRCO MFG CORPORATION
Alloway PaulQ32 Bio Inc.
Angella Frank G.VIRCO MFG CORPORATION
ARCH Venture Fund IX, L.P.VIRCO MFG CORPORATION
ARCH Venture Fund IX Overage, L.P.VIRCO MFG CORPORATION
ARCH Venture Fund VIII, L.P.Q32 Bio Inc.
ARCH Venture Fund VIII Overage, L.P.Q32 Bio Inc.
ARCH Venture Partners IX, LLCVIRCO MFG CORPORATION
ARCH Venture Partners IX, L.P.VIRCO MFG CORPORATION
ARCH Venture Partners IX Overage, L.P.VIRCO MFG CORPORATION
ARCH Venture Partners VIII, LLCQ32 Bio Inc.
ARCH Venture Partners VIII, L.P.Q32 Bio Inc.
Atlas Venture Associates IX, LLCIntellia Therapeutics, Inc.
Atlas Venture Associates IX, L.P.Intellia Therapeutics, Inc.
Atlas Venture Associates Opportunity III, LLCQ32 Bio Inc.
Atlas Venture Associates Opportunity III, L.P.Q32 Bio Inc.
Atlas Venture Associates Opportunity II, LLCQ32 Bio Inc.
Atlas Venture Associates Opportunity II, LPQ32 Bio Inc.
Atlas Venture Associates Opportunity I, LLCQ32 Bio Inc.
Atlas Venture Associates Opportunity I, L.P.Q32 Bio Inc.
Atlas Venture Associates X, LLCQ32 Bio Inc.
ATLAS VENTURE ASSOCIATES X, L.P.Q32 Bio Inc.
Atlas Venture Fund IX, L.P.Intellia Therapeutics, Inc.
Atlas Venture Fund X, L.P.Q32 Bio Inc.
Atlas Venture Opportunity Fund II, L.P.Q32 Bio Inc.
Atlas Venture Opportunity Fund Ill, L.P.Q32 Bio Inc.
Atlas Venture Opportunity Fund I, L.P.Q32 Bio Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →